INNOCOLL PHARMS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INNOCOLL PHARMS, and what generic alternatives to INNOCOLL PHARMS drugs are available?
INNOCOLL PHARMS has one approved drug.
There are two US patents protecting INNOCOLL PHARMS drugs.
There are fifty-five patent family members on INNOCOLL PHARMS drugs in twenty-three countries.
Summary for INNOCOLL PHARMS
| International Patents: | 55 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for INNOCOLL PHARMS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innocoll Pharms | XARACOLL | bupivacaine hydrochloride | IMPLANT;IMPLANTATION | 209511-001 | Aug 28, 2020 | DISCN | Yes | No | RE47826 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Innocoll Pharms | XARACOLL | bupivacaine hydrochloride | IMPLANT;IMPLANTATION | 209511-001 | Aug 28, 2020 | DISCN | Yes | No | 11,746,141 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for INNOCOLL PHARMS Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2582368 | ⤷ Subscribe |
| Serbia | 61726 | ⤷ Subscribe |
| Denmark | 3255106 | ⤷ Subscribe |
| World Intellectual Property Organization (WIPO) | 2013104687 | ⤷ Subscribe |
| Spain | 2718542 | ⤷ Subscribe |
| Spain | 2645445 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
